
ToxiProofAI is pioneering personalized drug safety using AI-driven Pharmacogenomics (PGx). The company offers a range of solutions including a PGx Discovery Lab, preclinical and clinical support, and a cloud-based SaaS platform for safety prediction. Their innovative approach leverages advanced biosensors and toxicology expertise to ensure rigorous evaluation of new therapies, setting a high standard in pharmaceutical safety and efficacy. ToxiProofAI aims to optimize clinical trial designs and dosing strategies, making drug development safer and more efficient.

ToxiProofAI is pioneering personalized drug safety using AI-driven Pharmacogenomics (PGx). The company offers a range of solutions including a PGx Discovery Lab, preclinical and clinical support, and a cloud-based SaaS platform for safety prediction. Their innovative approach leverages advanced biosensors and toxicology expertise to ensure rigorous evaluation of new therapies, setting a high standard in pharmaceutical safety and efficacy. ToxiProofAI aims to optimize clinical trial designs and dosing strategies, making drug development safer and more efficient.